332 related articles for article (PubMed ID: 9050873)
21. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.
Fujii H; Nakagawa Y; Schindler U; Kawahara A; Mori H; Gouilleux F; Groner B; Ihle JN; Minami Y; Miyazaki T
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5482-6. PubMed ID: 7777534
[TBL] [Abstract][Full Text] [Related]
22. Activation of the interleukin 2 receptor: a possible role for tyrosine phosphatases.
Ellery JM; Kempshall SJ; Nicholls PJ
Cell Signal; 2000 Jun; 12(6):367-73. PubMed ID: 10889465
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain.
Adachi M; Ishino M; Torigoe T; Minami Y; Matozaki T; Miyazaki T; Taniguchi T; Hinoda Y; Imai K
Oncogene; 1997 Apr; 14(13):1629-33. PubMed ID: 9129156
[TBL] [Abstract][Full Text] [Related]
24. Regulation of IL-2 signaling.
Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Sugamura K
Leukemia; 1997 Apr; 11 Suppl 3():416-7. PubMed ID: 9209410
[TBL] [Abstract][Full Text] [Related]
25. Identification of a variable region within the cytoplasmic tail of the IL-2 receptor beta chain that is required for growth signal transduction.
Liu KD; Lai SY; Goldsmith MA; Greene WC
J Biol Chem; 1995 Sep; 270(38):22176-81. PubMed ID: 7545674
[TBL] [Abstract][Full Text] [Related]
26. The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression.
Reichel M; Nelson BH; Greenberg PD; Rothman PB
J Immunol; 1997 Jun; 158(12):5860-7. PubMed ID: 9190938
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 2-induced activation of JAK3: possible involvement in signal transduction for c-myc induction and cell proliferation.
Asao H; Tanaka N; Ishii N; Higuchi M; Takeshita T; Nakamura M; Shirasawa T; Sugamura K
FEBS Lett; 1994 Sep; 351(2):201-6. PubMed ID: 8082765
[TBL] [Abstract][Full Text] [Related]
28. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
29. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
30. Efficient internalization of IL-2 depends on the distal portion of the cytoplasmic tail of the IL-2R common gamma-chain and a lymphoid cell environment.
Yu A; Olosz F; Choi CY; Malek TR
J Immunol; 2000 Sep; 165(5):2556-62. PubMed ID: 10946282
[TBL] [Abstract][Full Text] [Related]
31. JAK3 protein tyrosine kinase mediates interleukin-7-induced activation of phosphatidylinositol-3' kinase.
Sharfe N; Dadi HK; Roifman CM
Blood; 1995 Sep; 86(6):2077-85. PubMed ID: 7662955
[TBL] [Abstract][Full Text] [Related]
32. Receptor expression is essential for proliferation induced by dimerized Jak kinases.
Fujii H
Biochem Biophys Res Commun; 2008 Jun; 370(4):557-60. PubMed ID: 18381062
[TBL] [Abstract][Full Text] [Related]
33. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
Kolenko V; Wang Q; Riedy MC; O'Shea J; Ritz J; Cathcart MK; Rayman P; Tubbs R; Edinger M; Novick A; Bukowski R; Finke J
J Immunol; 1997 Sep; 159(6):3057-67. PubMed ID: 9300731
[TBL] [Abstract][Full Text] [Related]
34. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation.
Cohney SJ; Sanden D; Cacalano NA; Yoshimura A; Mui A; Migone TS; Johnston JA
Mol Cell Biol; 1999 Jul; 19(7):4980-8. PubMed ID: 10373548
[TBL] [Abstract][Full Text] [Related]
35. Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity.
Gaffen SL; Lai SY; Ha M; Liu X; Hennighausen L; Greene WC; Goldsmith MA
J Biol Chem; 1996 Aug; 271(35):21381-90. PubMed ID: 8702919
[TBL] [Abstract][Full Text] [Related]
36. Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3',5'-monophosphate and phosphatases.
Zhang H; Conrad DM; Butler JJ; Zhao C; Blay J; Hoskin DW
J Immunol; 2004 Jul; 173(2):932-44. PubMed ID: 15240680
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids.
Bianchi M; Meng C; Ivashkiv LB
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9573-8. PubMed ID: 10920190
[TBL] [Abstract][Full Text] [Related]
38. Alternate signalling pathways from the interleukin-2 receptor.
Ellery JM; Nicholls PJ
Cytokine Growth Factor Rev; 2002 Feb; 13(1):27-40. PubMed ID: 11750878
[TBL] [Abstract][Full Text] [Related]
39. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
[TBL] [Abstract][Full Text] [Related]
40. A constitutively activated chimeric cytokine receptor confers factor-independent growth in hematopoietic cell lines.
Shikama Y; Barber DL; D'Andrea AD; Sieff CA
Blood; 1996 Jul; 88(2):455-64. PubMed ID: 8695792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
